BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19001185)

  • 1. Deletion of inducible nitric oxide synthase provides cardioprotection in mice with 2-kidney, 1-clip hypertension.
    Sun Y; Carretero OA; Xu J; Rhaleb NE; Yang JJ; Pagano PJ; Yang XP
    Hypertension; 2009 Jan; 53(1):49-56. PubMed ID: 19001185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate-salt hypertension.
    Sun Y; Carretero OA; Xu J; Rhaleb NE; Wang F; Lin C; Yang JJ; Pagano PJ; Yang XP
    Hypertension; 2005 Dec; 46(6):1355-61. PubMed ID: 16286571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of inducible nitric oxide synthase in cardiac function and remodeling in mice with heart failure due to myocardial infarction.
    Liu YH; Carretero OA; Cingolani OH; Liao TD; Sun Y; Xu J; Li LY; Pagano PJ; Yang JJ; Yang XP
    Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2616-23. PubMed ID: 16055518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular exercise alleviates renovascular hypertension-induced cardiac/endothelial dysfunction and oxidative injury in rats.
    Kumral ZN; Sener G; Ozgur S; Koc M; Suleymanoglu S; Hurdag C; Yegen BC
    J Physiol Pharmacol; 2016 Feb; 67(1):45-55. PubMed ID: 27010894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
    Zhang P; Xu X; Hu X; van Deel ED; Zhu G; Chen Y
    Circ Res; 2007 Apr; 100(7):1089-98. PubMed ID: 17363700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nuclear Factor kappaB Inhibitor Pyrrolidine Dithiocarbamate Prevents Cardiac Remodelling and Matrix Metalloproteinase-2 Up-Regulation in Renovascular Hypertension.
    Cau SB; Guimaraes DA; Rizzi E; Ceron CS; Gerlach RF; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):234-41. PubMed ID: 25816715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.
    Heusch P; Aker S; Boengler K; Deindl E; van de Sand A; Klein K; Rassaf T; Konietzka I; Sewell A; Menazza S; Canton M; Heusch G; Di Lisa F; Schulz R
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H446-53. PubMed ID: 20511413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac fibrogenesis following infarction in mice with deletion of inducible nitric oxide synthase.
    Lu L; Chen SS; Hassid A; Sun Y
    Am J Med Sci; 2008 Jun; 335(6):431-8. PubMed ID: 18552572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
    Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible nitric oxide synthase contributes to insulin resistance and cardiac dysfunction after burn injury in mice.
    Guo Y; You Y; Lv D; Yan J; Shang FF; Wang X; Zhang C; Fan Q; Luo S
    Life Sci; 2019 Dec; 239():116912. PubMed ID: 31634465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic diabetic nephropathy: role of inducible nitric oxide synthase.
    Trachtman H; Futterweit S; Pine E; Mann J; Valderrama E
    Pediatr Nephrol; 2002 Jan; 17(1):20-9. PubMed ID: 11793130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
    Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
    Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model.
    Tyagi N; Moshal KS; Lominadze D; Ovechkin AV; Tyagi SC
    Can J Physiol Pharmacol; 2005 Jul; 83(7):583-94. PubMed ID: 16091784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
    Scherrer-Crosbie M; Ullrich R; Bloch KD; Nakajima H; Nasseri B; Aretz HT; Lindsey ML; Vançon AC; Huang PL; Lee RT; Zapol WM; Picard MH
    Circulation; 2001 Sep; 104(11):1286-91. PubMed ID: 11551881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
    Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
    World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits.
    Signolet IL; Bousquet PP; Monassier LJ
    Am J Hypertens; 2008 Jan; 21(1):54-60. PubMed ID: 18091744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E; Guimaraes DA; Ceron CS; Prado CM; Pinheiro LC; Martins-Oliveira A; Gerlach RF; Tanus-Santos JE
    Free Radic Biol Med; 2014 Aug; 73():308-17. PubMed ID: 24933619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.
    Henderson BC; Sen U; Reynolds C; Moshal KS; Ovechkin A; Tyagi N; Kartha GK; Rodriguez WE; Tyagi SC
    Int J Biol Sci; 2007 Sep; 3(6):385-92. PubMed ID: 17848984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.